Fibrosis
Pharmaxis Begins Phase III Cystic Fibrosis Trial
Published in Healthcare Mergers, Acquisitions and Ventures Week, May 5th, 2007
The Phase III trial is being conducted initially in 40 hospitals across Australia, the UK and Ireland, and is the final clinical step before Pharmaxis seeks approval to market Bronchitol for cystic fibrosis in the European Union, Australia and elsewhere.
Pharmaxis Chief Executive Officer Dr Alan Robertson said: "It's great news to get this trial underway and it represents significant progress for our cystic fibrosis programme. For the first time, we are offering...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 3D Systems Corporation
3D Systems Announces New Hearing Aid Manufacturing System - Access Pharmaceuticals, Inc.
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals - ACS, Inc.
ACS EDI Gateway Receives Electronic Healthcare Accreditation From Independent Agency - AcuNetx, Inc.
AcuNetx Buys Back Nearly One Percent of Its Outstanding Shares - Acusis
Acusis Acquires Digital Records Corporation Adding Capabilities for Significant Growth - Adaltis
Adaltis Receives Important Commitment for EclecticaTM Instruments in Mexico - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
